| Product Name | MF | CAS | Details |
|---|
| QM31 | C39H38Cl4N4O4 | 937735-00-7 | Details |
| Arrhythmias-Targeting Compound 1 | C22H32N4O2 | 335619-12-0 | Details |
| MPT0B392 | C19H20N2O6S | 1346169-92-3 | Details |
| WS-383 free base | C18H20ClN9S2 | 2247543-65-1 | Details |
| Heterocyclyl carbamate derivative 1 | C26H29N3O2 | 168830-01-1 | Details |
| Acetylhydrolase-IN-1 | C23H48NO7P | 79637-91-5 | Details |
| N-Methyl Duloxetine hydrochloride | C19H22ClNOS | 916135-70-1 | Details |
| YM-264 | C24H32N4OS.C4H4O4 | 131888-54-5 | Details |
| Nampt-IN-3 | C29H25N7O2 | 2121591-52-2 | Details |
| ZK168281 | C32H46O5 | 186371-96-0 | Details |
| Zabofloxacin | C19H20FN5O4 | 219680-11-2 | Details |
| WQ3810 | C22H22F3N5O3 | 888032-58-4 | Details |
| Wnt/β-catenin agonist 1 | C22H25N3O2 | 2305372-67-0 | Details |
| PD-1-IN-18 | C11H17N5O8 | 1673534-97-8 | Details |
| UCSF924 | C20H22N2O2 | 1434515-70-4 | Details |
| Tuberculosis inhibitor 1 | C34H37N5O3 | 2230810-28-1 | Details |
| S-1-Propenyl-L-cysteine | C6H11NO2S | 52438-09-2 | Details |
| PF-04634817 succinate | C29H42F3N5O7 | 2140301-98-8 | Details |
| Ro 41-3290 | C24H21ClN2O3 | 143943-72-0 | Details |
| PERK-IN-2 | C23H18F3N5O | 1337531-83-5 | Details |
| TMP780 | C31H30N2O4 | 1422053-03-9 | Details |
| S-methyl DM1 | C36H50ClN3O10S | 912569-84-7 | Details |
| PI3K-IN-6 | C17H14Cl2FN9O | 1842380-77-1 | Details |
| SSR-241586 | C32H42Cl2N4O3 | 1239279-30-1 | Details |
| SARS-CoV-2-IN-1 | C31H39N5O7 | 2412965-59-2 | Details |
| SGL5213 | C37H55N3O8 | 1240305-17-2 | Details |
| WDR5-IN-4 | C25H22Cl2FN5O | 2407457-36-5 | Details |
| TLR7 agonist 1 | C21H25N5O | 2178156-33-5 | Details |
| PI3K/HDAC-IN-1 | C22H25FN4O4 | 2361418-52-0 | Details |
| SGLT inhibitor-1 | C24H27FO8 | 2247314-23-2 | Details |
| RORγt Inverse agonist 8 | C26H33N7O2 | 2079892-79-6 | Details |
| PI3K-IN-10 | C23H19ClN6O | 2211922-64-2 | Details |
| TD-0212 | C28H34FN3O4S | 1073549-10-6 | Details |
| (Rac)-BAY-985 | C27H30F3N9O | 2101925-20-4 | Details |
| USP7-IN-3 | C29H31F3N6O3 | 2202738-42-7 | Details |
| CBP/p300-IN-5 | C29H27F5N6O4 | 1889284-33-6 | Details |
| TTT-28 | C31H31N3O6S | 1609138-51-3 | Details |
| T-448 free base | C17H20N4OS | 1597426-52-2 | Details |
| SGK1-IN-2 | C17H12Cl2N6O2S | 1426214-64-3 | Details |
| (R)-PS210 | C19H15F3O5 | 1410101-89-1 | Details |
| SMP-028 | C23H26FN5O2S | 914389-14-3 | Details |
| KP-23172 | C10H4N6O | 331253-86-2 | Details |
| Tubulin inhibitor 7 | C21H14N2O4 | 1309925-41-4 | Details |
| (Rac)-E1R | C13H16N2O2 | 787623-60-3 | Details |
| SHR1653 | C21H21ClFN5O2 | 2231770-73-1 | Details |
| Tyk2-IN-3 | C25H24N6O3S2 | 1779493-12-7 | Details |
| SB-423557 | C28H36N2O4 | 351490-26-1 | Details |
| VP3.15 | C20H22N4OS | 1281681-54-6 | Details |
| UPF-648 sodium salt | C11H9Cl2NaO3 | 1465017-87-1 | Details |
| (Rac)-SEP-363856 | C9H13NOS | 1310426-29-9 | Details |
| Naminterol | C19H26N2O3 | 93047-40-6 | Details |
| β3-AR agonist 2 | C27H38N4O7S | 340757-05-3 | Details |
| MDM2-IN-1 | C23H21Cl2FN2O3 | 1410737-09-5 | Details |
| KRAS inhibitor-8 | C26H24ClF4N5O3 | 2022986-70-3 | Details |
| MBM-17 | C28H28N6O2 | 2083621-90-1 | Details |
| Mcl1-IN-11 | C38H41N3O5S2 | 2042211-13-0 | Details |
| KRAS inhibitor-6 | C27H30ClF2N5O3 | 2022986-61-2 | Details |
| LY88074 Methyl ether | C22H16O4S | 63675-88-7 | Details |
| LY 222306 | C19H23N5O7 | 154446-98-7 | Details |
| LY3020371 hydrochloride | C15 H15 F2 N O5 S . Cl H | 1377615-44-5 | Details |
| Lamivudine 13C,15N2 | C8H9N3O4S | 1391052-30-4 | Details |
| MS31 | C20H27N3O2 | 2366264-12-0 | Details |
| KRAS inhibitor-7 | C26H27ClF2N6O2 | 2022986-68-9 | Details |
| KRN2 | C27H23ClFNO4 | 248260-75-5 | Details |
| NK-1 Antagonist 1 | C25H23F6N5O2 | 873947-10-5 | Details |
| LY 541850 | C9H13NO4 | 852679-76-6 | Details |
| OP-1074 | C29H31NO4 | 1443752-76-8 | Details |
| NED-3238 | C17H28BN3O4 | 2389062-09-1 | Details |
| Mcl1-IN-9 | C37H39ClN4O4 | 1810769-31-3 | Details |
| Kv3 modulator 4 | C20H24N2O4 | 2173375-10-3 | Details |
| MT-3014 | C23H25F2N7O | 1332727-40-8 | Details |
| mTOR inhibitor-2 | C23H21N7O | 2219323-96-1 | Details |
| Nav1.7-IN-6 | C25H25ClF6N2O4S | 1788066-71-6 | Details |
| LSD1-IN-6 | C15H13BrN2O3 | 2035912-43-5 | Details |
| LSD1-IN-5 | C15H13BrN2O3 | 2035912-55-9 | Details |
| Voruciclib hydrochloride | C22H20Cl2F3NO5 | 1000023-05-1 | Details |
| Tagitinin C | 59979-56-5 | Details |
| KRAS G12C inhibitor 14 | C24H19ClF2N4O3 | 2349393-95-7 | Details |
| PC945 | C38H37F3N6O3 | 1931946-73-4 | Details |
| PRMT5-IN-1 | C19H19ClN4O5 | 2366149-83-7 | Details |
| UK-101 | C25H48N2O5Si | 1000313-40-5 | Details |
| L-692429 | C29H31N7O2 | 145455-23-8 | Details |
| αvβ1 integrin-IN-1 | C26H34N6O6S | 1689540-62-2 | Details |
| Vapendavir diphosphate | C21H29N4O7P | 1198151-75-5 | Details |
| XY101 | C25H20F7NO4S | 2349368-16-5 | Details |
| AZ-1355 | C17H17NO4 | 75451-07-9 | Details |
| NCGC00229600 | C30H29N3O3 | 1338824-20-6 | Details |
| PQCA | C22H20N4O3 | 1144504-35-7 | Details |
| Piperidine-MO-1 | C14H21ClFNO2S | 871351-61-0 | Details |
| CGRP antagonist 1 | C29H26N4O4 | 1123757-49-2 | Details |
| MBM-55S | C32H33FN6O6 | 2083624-07-9 | Details |
| LysRs-IN-2 | C17H16F3NO4 | 2170696-76-9 | Details |
| Topterone | C22H34O2 | 60607-35-4 | Details |
| MIV-247 | C17H24F3N3O4 | 1352817-76-5 | Details |
| RP 54275 | C27H43NO2 | 81364-78-5 | Details |
| 8011-6561 | C20H21NO | 968-63-8 | Details |
| Org30958 | C21H30O2S2 | 99957-90-1 | Details |
| PI3Kγ inhibitor 2 | C20H18F3N5O3 | 1315538-79-4 | Details |
| SCH 42495 | C20H29NO4S2 | 136511-43-8 | Details |
| RR-11a | C24H28N6O10 | 1361390-56-8 | Details |
| Product Total： Product Page： | ||||
| 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 | ||||